LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
88993-1
|
Acute kidney injury risk
|
Likelihood
|
Pt
|
^Patient
|
Qn
|
Calculated.NephroCheck
|
CHEM
| 1 |
Acute kidney injury risk [Likelihood] by Calculated by NephroCheck
|
Acute kidney injury risk NephroCheck
| null |
ACTIVE
|
2.64
|
2.69
|
88994-9
|
Arachidonate/Fatty acids.C14-C24
|
SFr
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma
|
AA/Fatty acids.C14-C24 SFr SerPl
| null |
ACTIVE
|
2.64
|
2.73
|
88995-6
|
Docosahexaenoate/Fatty acids.C14-C24
|
SFr
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma
|
DHA/Fatty acids.C14-C24 SFr SerPl
| null |
ACTIVE
|
2.64
|
2.73
|
88996-4
|
Eicosapentaenoate/Arachidonate
|
SRto
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma
|
EPA/AA SerPl-sRto
| null |
ACTIVE
|
2.64
|
2.73
|
8899-7
|
Arterial pulse intensity
|
Force
|
Pt
|
Brachial artery.right
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Brachial artery - right by palpation
|
Pulse intensity Brach a-R Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
88997-2
|
Eicosapentaenoate/Fatty acids.C14-C24
|
SFr
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma
|
EPA/Fatty acids.C14-C24 SFr SerPl
| null |
ACTIVE
|
2.64
|
2.73
|
88998-0
|
Eicosapentaenoate+Docosahexaenoate/Fatty acids.C14-C24
|
SFr
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Omega-3 (EPA+DHA) index in Serum or Plasma
|
Omega-3 index SFr SerPl
| null |
ACTIVE
|
2.64
|
2.73
|
88999-8
|
Eicosapentaenoate+docosahexaenoate/Fatty acids.C14-C24 index risk
|
Imp
|
Pt
|
Ser/Plas
|
Ord
| null |
CHEM
| 1 |
Omega-3 (EPA+DHA) index risk in Serum or Plasma
|
Omega-3 index risk SFr SerPl
| null |
ACTIVE
|
2.64
|
2.73
|
89000-4
|
Ethyl glucuronide
|
MCnt
|
Pt
|
Hair
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Ethyl glucuronide [Mass/mass] in Hair by Confirmatory method
|
Ethyl glucuronide Hair Cfm-mCnt
| null |
ACTIVE
|
2.64
|
2.65
|
89001-2
|
Cancer-associated gene Ab
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
CAGE Ab [Units/volume] in Serum or Plasma by Immunoassay
|
CAGE Ab SerPl IA-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89002-0
|
GBU4-5 Ab
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
GBU4-5 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
GBU4-5 Ab SerPl IA-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
8900-3
|
Arterial pulse intensity
|
Force
|
Pt
|
Carotid artery.left
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Carotid artery - left by palpation
|
Pulse intensity Carot a-L Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
89003-8
|
HuD Ab
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
HuD Ab [Units/volume] in Serum or Plasma by Immunoassay
|
HuD Ab SerPl IA-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89004-6
|
Melanoma-associated antigen A4 Ab
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
MAGE A4 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
MAGE A4 Ab SerPl IA-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89005-3
|
NY-ESO-1 Ab
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
NY-ESO-1 Ab SerPl IA-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89006-1
|
p53 Ab
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
p53 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
p53 Ab SerPl IA-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89007-9
|
SOX-2 Ab
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
SOX-2 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
SOX-2 Ab SerPl IA-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89008-7
|
Station name
|
ID
|
Pt
|
EMS system
|
Nom
| null |
TRAUMA
| 2 |
Station name [Identifier] EMS system
|
Station name EMS Sys
| null |
ACTIVE
|
2.64
|
2.7
|
89009-5
|
Encounter location
|
Type
|
Pt
|
^Patient
|
Nom
| null |
TRAUMA
| 2 |
Encounter location [Type]
|
Encounter location Type
| null |
ACTIVE
|
2.64
|
2.7
|
89010-3
|
EMS physician name
|
Pn
|
Pt
|
Provider
|
Nom
| null |
TRAUMA
| 2 |
EMS physician name
|
EMS MD name
| null |
ACTIVE
|
2.64
|
2.7
|
8901-1
|
Arterial pulse intensity
|
Force
|
Pt
|
Carotid artery.right
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Carotid artery - right by palpation
|
Pulse intensity Carot a-R Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
89011-1
|
EMS assistant name
|
Pn
|
Pt
|
Provider
|
Nom
| null |
TRAUMA
| 2 |
EMS assistant name
|
EMS assistant name
| null |
ACTIVE
|
2.64
|
2.7
|
89012-9
|
EMS assistant qualification
|
Type
|
Pt
|
Provider
|
Nom
| null |
TRAUMA
| 2 |
EMS assistant qualification
|
EMS assistant qual
| null |
ACTIVE
|
2.64
|
2.7
|
89013-7
|
Certified first responder was on site when EMS unit arrived
|
Find
|
Pt
|
^Patient
|
Ord
| null |
TRAUMA
| 2 |
Certified first responder was on site when EMS unit arrived
|
Cert first responder on site pre EMS
| null |
ACTIVE
|
2.64
|
2.7
|
89014-5
|
Oxygen was used for preoxygenation
|
Find
|
Pt
|
^Patient
|
Nom
| null |
PULM
| 2 |
Oxygen was used for preoxygenation
|
Oxygen for preoxygenation
| null |
ACTIVE
|
2.64
|
2.7
|
89015-2
|
Pure tone threshold audiometry panel
|
-
|
Pt
|
Ear
|
-
| null |
PANEL.CLIN
| 2 |
Pure tone threshold audiometry panel
|
Pure tone thresh Pnl
| null |
ACTIVE
|
2.64
|
2.72
|
89016-0
|
Hearing threshold^1000 Hz
|
RelSoundInt
|
Pt
|
Ear.left
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - left --1000 Hz
|
Hearing threshold 1000 Hz Ear-L
| null |
ACTIVE
|
2.64
|
2.64
|
89017-8
|
Hearing threshold^1000 Hz
|
RelSoundInt
|
Pt
|
Ear.right
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - right --1000 Hz
|
Hearing threshold 1000 Hz Ear-R
| null |
ACTIVE
|
2.64
|
2.64
|
89018-6
|
Hearing threshold^2000 Hz
|
RelSoundInt
|
Pt
|
Ear.left
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - left --2000 Hz
|
Hearing threshold 2000 Hz Ear-L
| null |
ACTIVE
|
2.64
|
2.64
|
89019-4
|
Hearing threshold^2000 Hz
|
RelSoundInt
|
Pt
|
Ear.right
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - right --2000 Hz
|
Hearing threshold 2000 Hz Ear-R
| null |
ACTIVE
|
2.64
|
2.64
|
89020-2
|
Hearing threshold^3000 Hz
|
RelSoundInt
|
Pt
|
Ear.left
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - left --3000 Hz
|
Hearing threshold 3000 Hz Ear-L
| null |
ACTIVE
|
2.64
|
2.64
|
89021-0
|
Hearing threshold^3000 Hz
|
RelSoundInt
|
Pt
|
Ear.right
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - right --3000 Hz
|
Hearing threshold 3000 Hz Ear-R
| null |
ACTIVE
|
2.64
|
2.64
|
89022-8
|
Hearing threshold^4000 Hz
|
RelSoundInt
|
Pt
|
Ear.left
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - left --4000 Hz
|
Hearing threshold 4000 Hz Ear-L
| null |
ACTIVE
|
2.64
|
2.64
|
89023-6
|
Hearing threshold^4000 Hz
|
RelSoundInt
|
Pt
|
Ear.right
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - right --4000 Hz
|
Hearing threshold 4000 Hz Ear-R
| null |
ACTIVE
|
2.64
|
2.64
|
89024-4
|
Hearing threshold^500 Hz
|
RelSoundInt
|
Pt
|
Ear.left
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - left --500 Hz
|
Hearing threshold 500 Hz Ear-L
| null |
ACTIVE
|
2.64
|
2.64
|
89025-1
|
Hearing threshold^500 Hz
|
RelSoundInt
|
Pt
|
Ear.right
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - right --500 Hz
|
Hearing threshold 500 Hz Ear-R
| null |
ACTIVE
|
2.64
|
2.64
|
89026-9
|
Hearing threshold^6000 Hz
|
RelSoundInt
|
Pt
|
Ear.left
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - left --6000 Hz
|
Hearing threshold 6000 Hz Ear-L
| null |
ACTIVE
|
2.64
|
2.64
|
89027-7
|
Hearing threshold^6000 Hz
|
RelSoundInt
|
Pt
|
Ear.right
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - right --6000 Hz
|
Hearing threshold 6000 Hz Ear-R
| null |
ACTIVE
|
2.64
|
2.64
|
89028-5
|
Hearing threshold^8000 Hz
|
RelSoundInt
|
Pt
|
Ear.left
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - left --8000 Hz
|
Hearing threshold 8000 Hz Ear-L
| null |
ACTIVE
|
2.64
|
2.64
|
8902-9
|
Arterial pulse intensity
|
Force
|
Pt
|
Dorsal pedal artery.left
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Dorsal pedal artery - left by palpation
|
Pulse intensity Dors pedal a-L Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
89029-3
|
Hearing threshold^8000 Hz
|
RelSoundInt
|
Pt
|
Ear.right
|
Qn
| null |
AUDIO
| 2 |
Hearing threshold Ear - right --8000 Hz
|
Hearing threshold 8000 Hz Ear-R
| null |
ACTIVE
|
2.64
|
2.64
|
89030-1
|
Progress note
|
Find
|
Pt
|
{Setting}
|
Doc
|
Physical medicine and rehab
|
DOC.ONTOLOGY
| 2 |
Physical medicine and rehab Progress note
|
PM+R Prog note
| null |
ACTIVE
|
2.64
|
2.73
|
89031-9
|
Consultation note
|
Find
|
Pt
|
Telehealth
|
Doc
|
Hematology
|
DOC.ONTOLOGY
| 2 |
Hematology Telehealth Consult note
|
Hematology Telehealth Consult note
| null |
ACTIVE
|
2.64
|
2.64
|
89032-7
|
Consultation note
|
Find
|
Pt
|
Telehealth
|
Doc
|
Nephrology
|
DOC.ONTOLOGY
| 2 |
Nephrology Telehealth Consult note
|
Nephrology Telehealth Consult note
| null |
ACTIVE
|
2.64
|
2.64
|
89033-5
|
Consultation note
|
Find
|
Pt
|
Telehealth
|
Doc
|
Urology
|
DOC.ONTOLOGY
| 2 |
Urology Telehealth Consult note
|
Urology Telehealth Consult note
| null |
ACTIVE
|
2.64
|
2.64
|
89034-3
|
Initial evaluation note
|
Find
|
Pt
|
{Setting}
|
Doc
|
Vascular neurology
|
DOC.ONTOLOGY
| 2 |
Vascular neurology Initial evaluation note
|
Vasc Neuro Initial eval note
| null |
ACTIVE
|
2.64
|
2.64
|
89035-0
|
Note
|
Find
|
Pt
|
{Setting}
|
Doc
|
Sleep medicine.physician
|
DOC.ONTOLOGY
| 2 |
Sleep medicine Physician Note
|
Sleep medicine MD Note
| null |
ACTIVE
|
2.64
|
2.64
|
89036-8
|
Note
|
Find
|
Pt
|
{Setting}
|
Doc
|
Trauma
|
DOC.ONTOLOGY
| 2 |
Trauma Note
|
Trauma Note
| null |
ACTIVE
|
2.64
|
2.64
|
8903-7
|
Arterial pulse intensity
|
Force
|
Pt
|
Dorsal pedal artery
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Dorsal pedal artery by palpation
|
Pulse intensity Dors pedal a Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
89037-6
|
CDKN2A gene deletion+duplication & full mutation analysis
|
Find
|
Pt
|
Bld/Tiss
|
Doc
|
Molgen
|
MOLPATH
| 1 |
CDKN2A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
|
CDKN2A Del+Dup + Full Mut Anl Bld/T
| null |
ACTIVE
|
2.64
|
2.65
|
89038-4
|
CHEK2 gene deletion+duplication & full mutation analysis
|
Find
|
Pt
|
Bld/Tiss
|
Doc
|
Molgen
|
MOLPATH
| 1 |
CHEK2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
|
CHEK2 Del+Dup + Full Mut Anl Bld/T
| null |
ACTIVE
|
2.64
|
2.65
|
89039-2
|
MSH2 gene deletion+duplication & full mutation analysis & EPCAM gene exons 8 & 9 deletion+duplication
|
Find
|
Pt
|
Bld/Tiss
|
Doc
|
Molgen
|
MOLPATH
| 1 |
MSH2 gene deletion+duplication and full mutation analysis and EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method
|
MSH2 DelDup+Full EPCAM 8+9 DelDup Bld/T
| null |
ACTIVE
|
2.64
|
2.65
|
890-4
|
Blood group antibody screen
|
PrThr
|
Pt
|
Ser/Plas
|
Ord
| null |
BLDBK
| 1 |
Blood group antibody screen [Presence] in Serum or Plasma
|
Bld gp Ab Scn SerPl Ql
| null |
ACTIVE
|
1.0
|
2.73
|
89040-0
|
Rubella virus Ab
|
PrThr
|
Pt
|
Ser
|
Ord
|
IF
|
MICRO
| 1 |
Rubella virus Ab [Presence] in Serum by Immunofluorescence
|
RUBV Ab Ser Ql IF
| null |
ACTIVE
|
2.64
|
2.64
|
89041-8
|
Lung cancer antibody
|
Imp
|
Pt
|
Ser/Plas
|
Nom
|
IA
|
SERO
| 1 |
Lung cancer antibody [Interpretation] in Serum or Plasma by Immunoassay
|
Lung cancer antibody SerPl IA-Imp
|
EarlyCDT® is a registered trademark of Oncimmune. Used with permission.
|
ACTIVE
|
2.64
|
2.73
|
89042-6
|
Eszopiclone
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
Eszopiclone [Mass/volume] in Urine
|
Eszopiclone Ur-mCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89043-4
|
Zopiclone-N-oxide
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
Zopiclone-N-oxide [Mass/volume] in Urine
|
Zopiclone-N-oxide Ur-mCnc
| null |
ACTIVE
|
2.64
|
2.73
|
89044-2
|
Basic metabolic & albumin panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.CHEM
| 1 |
Basic metabolic and albumin panel - Serum or Plasma
|
Basic metabolic & albumin panel SerPl
| null |
ACTIVE
|
2.64
|
2.68
|
8904-5
|
Arterial pulse intensity
|
Force
|
Pt
|
Femoral artery.left
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Femoral artery - left by palpation
|
Pulse intensity Fem a-L Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.73
|
89045-9
|
Indicate the patient's primary medical condition category
|
Find
|
Pt
|
^Patient
|
Nom
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Indicate the patient's primary medical condition category [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.65
|
89046-7
|
MDS v3.0 - RAI v1.17.2 - Skin conditions - ND, SD
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Skin conditions - ND, SD [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.68
|
89047-5
|
MDS v3.0 - RAI v1.16.1 - Skin conditions - NOD, SOD
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.16.1 - Skin conditions - NOD, SOD [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.65
|
89048-3
|
MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NC
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NC [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.7
|
89049-1
|
MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NP, NQ, SP
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NP, NQ, SP [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.7
|
89050-9
|
MDS v3.0 - RAI v1.15.1, v1.16.1 - Bladder and bowel - NS, NO, SS, SO
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.15.1, v1.16.1 - Bladder and bowel - NS, NO, SS, SO [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.64
|
89051-7
|
MDS v3.0 - RAI v1.17.2 - Skin conditions - IPA
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Skin conditions - IPA [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.68
|
8905-2
|
Arterial pulse intensity
|
Force
|
Pt
|
Femoral artery.right
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Femoral artery - right by palpation
|
Pulse intensity Fem a-R Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
89052-5
|
MDS v3.00 - RAI v1.15.1 - Skin conditions
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.00 - RAI v1.15.1 - Skin conditions [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.64
|
89053-3
|
MDS v3.0 - RAI v1.15.1 - Skin conditions - NOD, SOD
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.15.1 - Skin conditions - NOD, SOD [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.64
|
89054-1
|
Circulatory assistive device(s) used^preoperative
|
Prid
|
Pt
|
^Patient
|
Nom
| null |
CARD.PROC
| 2 |
Circulatory assistive device(s) used [Identifier] --preoperative
|
Circ assist devices used Preop
| null |
ACTIVE
|
2.64
|
2.64
|
89055-8
|
Circulatory assistive device(s) used^postoperative
|
Prid
|
Pt
|
^Patient
|
Nom
| null |
CARD.PROC
| 2 |
Circulatory assistive device(s) used [Identifier] --postoperative
|
Circ assist devices used Postop
| null |
ACTIVE
|
2.64
|
2.64
|
89056-6
|
Circulatory assistive device(s) used^during surgery
|
Prid
|
Pt
|
^Patient
|
Nom
| null |
CARD.PROC
| 2 |
Circulatory assistive device(s) used [Identifier] --during surgery
|
Circ assist devices used in Surg
| null |
ACTIVE
|
2.64
|
2.64
|
89057-4
|
Permission to receive text messages
|
Find
|
Pt
|
^Patient
|
Ord
| null |
ADMIN.PATIENT
| 2 |
Permission to receive text messages
|
Permission text messages
| null |
ACTIVE
|
2.64
|
2.71
|
89058-2
|
Email address
|
EmailAddr
|
Pt
|
^Contact
|
Nom
| null |
ADMIN
| 2 |
Contact email address
|
Contact email address
| null |
ACTIVE
|
2.64
|
2.71
|
89059-0
|
Secondary contact name
|
Pn
|
Pt
|
^Contact
|
Nom
| null |
ADMIN
| 2 |
Secondary contact name
|
Secondary contact name
| null |
ACTIVE
|
2.64
|
2.71
|
8906-0
|
Arterial pulse intensity
|
Force
|
Pt
|
Popliteal artery.left
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Popliteal artery - left by palpation
|
Pulse intensity Popliteal a-L Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
89060-8
|
Phone number
|
Tele
|
Pt
|
^Contact
|
Nom
| null |
ADMIN
| 2 |
Contact Phone number
|
Contact Phone #
| null |
ACTIVE
|
2.64
|
2.66
|
89061-6
|
Insurance group number
|
ID
|
Pt
|
^Patient
|
Nom
| null |
ADMIN.PATIENT.ID
| 2 |
Insurance group number [Identifier]
|
Ins group num
| null |
ACTIVE
|
2.64
|
2.71
|
89062-4
|
Severe bleeding related to aspirin use
|
Hx
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
History of Severe bleeding related to aspirin use
|
Hx of Severe bleeding due to aspirin use
| null |
ACTIVE
|
2.64
|
2.71
|
89063-2
|
Type of anticoagulant medication used
|
Type
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Type of anticoagulant medication used
|
Anticoagulant med used
| null |
ACTIVE
|
2.64
|
2.71
|
89064-0
|
Type of medication used for stomach upset
|
Type
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Type of medication used for stomach upset
|
Stomach upset meds
| null |
ACTIVE
|
2.64
|
2.71
|
89065-7
|
Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week
|
Type
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week
|
NSAID used several times a week
| null |
ACTIVE
|
2.64
|
2.71
|
89066-5
|
Year aspirin regimen began
|
Date
|
Pt
|
^Patient
|
Qn
| null |
H&P.HX
| 2 |
Year aspirin regimen began [Date]
|
Year aspirin regimen began
| null |
ACTIVE
|
2.64
|
2.71
|
89067-3
|
Type of blood thinning medication used
|
Type
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Type of blood thinning medication used
|
Blood thinning med used
| null |
ACTIVE
|
2.64
|
2.71
|
89068-1
|
Date aspirin discontinued
|
Date
|
Pt
|
^Patient
|
Qn
| null |
H&P.HX
| 2 |
Date aspirin discontinued
|
Date aspirin discontinued
| null |
ACTIVE
|
2.64
|
2.71
|
89069-9
|
Enteric coated aspirin tablet
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Enteric coated aspirin tablet
|
Enteric coated aspirin
| null |
ACTIVE
|
2.64
|
2.71
|
89070-7
|
ADAPTABLE patient reported item set
|
-
|
Pt
|
^Patient
|
-
|
ADAPTABLE
|
PANEL.SURVEY.GNHLTH
| 4 |
ADAPTABLE patient reported item set [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89071-5
|
Enrollment item set
|
-
|
Pt
|
^Patient
|
-
|
ADAPTABLE
|
PANEL.SURVEY.GNHLTH
| 4 |
Enrollment item set [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89072-3
|
Aspirin dose^post enrollment in ADAPTABLE study
|
Mass
|
Pt
|
^Patient
|
Qn
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
Aspirin dose--post enrollment in ADAPTABLE study [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89073-1
|
Reason for discontinuing aspirin use
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.GNHLTH
| 4 |
Reason for discontinuing aspirin use
| null | null |
ACTIVE
|
2.64
|
2.71
|
89074-9
|
Aspirin usage^post enrollment in ADAPTABLE study
|
Find
|
Pt
|
^Patient
|
Ord
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
Aspirin usage--post enrollment in ADAPTABLE study [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89075-6
|
Willing to change aspirin dose
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.GNHLTH
| 4 |
Willing to change aspirin dose
| null | null |
ACTIVE
|
2.64
|
2.71
|
89076-4
|
Aspirin usage^pre enrollment in ADAPTABLE study
|
Find
|
Pt
|
^Patient
|
Ord
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
Aspirin usage--pre enrollment in ADAPTABLE study [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89077-2
|
Adequacy of information on+time spent reading ADAPTABLE web site
|
Find
|
Pt
|
^Patient
|
Ord
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
Adequacy of information on+time spent reading ADAPTABLE web site [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
8907-8
|
Arterial pulse intensity
|
Force
|
Pt
|
Popliteal artery.right
|
Ord
|
Palpation
|
HRTRATE.MOLEC
| 2 |
Pulse intensity Popliteal artery - right by palpation
|
Pulse intensity Popliteal a-R Palpation
| null |
ACTIVE
|
1.0h(3)
|
2.38
|
89078-0
|
Hospitalization^post enrollment in ADAPTABLE study
|
Find
|
Pt
|
^Patient
|
Ord
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
History of hospitalization--post enrollment in ADAPTABLE study [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89079-8
|
Events^during hospitalization
|
Find
|
RptPeriod
|
^Patient
|
Nom
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
Events--during hospitalization [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89080-6
|
Satisfaction with using ADAPTABLE web site
|
Find
|
Pt
|
^Patient
|
Ord
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
Satisfaction with using ADAPTABLE web site [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89081-4
|
Aspirin dose^pre enrollment in ADAPTABLE study
|
Mass
|
Pt
|
Dose
|
Qn
|
ADAPTABLE
|
SURVEY.GNHLTH
| 4 |
Aspirin dose--pre enrollment in ADAPTABLE study Dose [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
89082-2
|
Early visit item set
|
-
|
Pt
|
^Patient
|
-
|
ADAPTABLE
|
PANEL.SURVEY.GNHLTH
| 4 |
Early visit item set [ADAPTABLE]
| null | null |
ACTIVE
|
2.64
|
2.71
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.